DrugPatentWatch Database Preview
Details for Patent: 9,072,857
Which drugs does patent 9,072,857 protect, and when does it expire?
Patent 9,072,857 protects XHANCE and is included in one NDA.
This patent has one hundred and fifty-four patent family members in twenty-six countries.
Summary for Patent: 9,072,857
| Title: | Nasal delivery device |
| Abstract: | A delivery device (20, 22) for and a method of delivering a substance to the nasal airway (1) of a subject, in particular the posterior region of the nasal airway, the delivery device comprising: a closure unit for causing the closure of the oropharyngeal velum of the subject; and a delivery unit for delivering a gas flow entraining a substance to one of the nostrils of the subject at such a driving pressure as to flow around the posterior margin of the nasal septum and out of the other nostril of the subject, wherein the delivery unit comprises a nosepiece (30, 40, 58, 82, 102, 132) which includes an outlet through which the gas flow is in use delivered to the one nostril and a sealing member for sealing the one nostril to the outlet such as in use to prevent the escape of the gas flow through the one nostril. |
| Inventor(s): | Djupesland; Per Gisle (Oslo, NO) |
| Assignee: | OptiNose AS (Oslo, NO) |
| Application Number: | 11/446,424 |
|
Patent Claim Types: see list of patent claims | Delivery; Device; |
Drugs Protected by US Patent 9,072,857
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,072,857
International Family Members for US Patent 9,072,857
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 285810 | Start Trial | |||
| Austria | 422923 | Start Trial | |||
| Austria | 427130 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
